Differences in genetic predisposition to high anxiety in two inbred rat strains: Role of substance P, diazepam binding inhibitor fragment and neuropeptide Y

Psychopharmacology

Volumn 154, Issue 4, 2001, Pages 327-335

  Sudakov, S K ^a   Medvedeva, O F ^a   Rusakova, I V ^a   Terebilina, N N ^a   Goldberg, S R ^a  

^a Department of Epidemiology   (Russian Federation)

Author keywords

Anxiety; Diazepam binding inhibitor; Neuropeptide Y; Rat; Substance P

Indexed keywords

DIAZEPAM BINDING INHIBITOR; NEUROPEPTIDE Y; SUBSTANCE P;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANXIETY; ARTICLE; CONTROLLED STUDY; GENETIC PREDISPOSITION; HIPPOCAMPUS; HYPOTHALAMUS; LICKING; MALE; MAZE TEST; MEASUREMENT; MESENCEPHALON; NONHUMAN; OPEN FIELD BEHAVIOR; PRIORITY JOURNAL; RAT; RAT STRAIN; REGULATORY MECHANISM; STRESS; TISSUE DISTRIBUTION;

ANIMALS; ANXIETY; BEHAVIOR, ANIMAL; GENETIC PREDISPOSITION TO DISEASE; HIPPOCAMPUS; HYPOTHALAMUS; MALE; MESENCEPHALON; NEUROPEPTIDE Y; RATS; RATS, INBRED F344; RATS, WISTAR; RECEPTORS, CYTOPLASMIC AND NUCLEAR; SPECIES SPECIFICITY; STRESS; SUBSTANCE P;

EID: 0035095451     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130000651     Document Type: Article

References (39)

1. Effect of the N-terminal fragment of substance P1-4 on the somatic manifestations of the stress reaction and on the catecholamine content of the adrenals in rats
2. Increase of seizure threshold and resistance to stress in rats after immunization against fragment of diazepam-binding inhibitor
3. Anxiolytic activity of NPY receptor agonists in the conflict test
4. Paradoxical differences in animal models of anxiety among the Roman rat lines
5. Male Fisher-344 and Lewis rats display differences in locomotor reactivity, but not in anxiety-related behaviours: Relationship with the hippocampal serotonergic system
6. Biological actions of cholecysto-kinin
7. Electrophysiological action of neuropeptide Y and it analogs: New measures for anxiolytic therapy?
8. Anxiolytic action of neurokinin1 receptor antagonist in the social interaction test
9. Anxiolytic-like action of neurokinin substance P administered systemically or into the nucleus basalis magnocellularis region
10. Neuropeptide Y: On overview of central distribution, functional aspects, and possible involvement in neuropsychiatric illnesses
11. Centrally administered neuropeptide Y (NPY) produces anxiolytic-like effects in animal anxiety models
12. Anxiolytic-like effect of neuropeptide Y (NPY), but not other peptides in an operant conflict test
13. Anxiolytic-like action of neuropeptide Y: Mediation by Y1 receptors in the amygdala, and dissociation from food effects
14. Specific binding of substance P amino-terminal heptapeptide [SP(1-7)] to mouse brain and spinal cord membranes
15. 1 receptor antagonist BIBP3226: Antagonism with diazepam
16. 13 36 microinjected into vicinity of locus coeruleus in rats
17. 1 receptor antagonist BIBP3226 administered into the dorsal periaqueductal gray matter in rats
18. The substance P amino-terminal metabolite substance P(1-7), administered peripherally, prevents the development of acute morphine tolerance and attenuates the expression of withdrawal in mice
19. Differences in the level of anxiety may be determined by density of the benzodiazepine receptors in the brain
20. Characterization of benzo-diazepine-sensitive behaviors in the A/J and C57BL/6J inbred strains of mice
21. Radioimmunoassay and characterization of enkephalins in rat tissues
22. Comparison of behavioral and central BDZ binding profile in three rat lines
23. Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat
24. Effects of diazepam and N(6)-cyclo-hexyladenosine on the level of diazepam-binding inhibitor in structures of the hippocampus during immobilization stress
25. A multiple-test study of anxiety-related behaviours in six inbred rat strains
26. Effects of cholecystokinin tetrapeptide and sulfated cholecystokinin octapeptide in rat models of anxiety
27. Benzodiazepine receptors in emotional and non-emotional mice: Comparison of four strains
28. Short-term resistant stress and s.c. saline injection alter the tissue levels of substance P and cholecystokinin in the peri-aqueductal grey and limbic regions of rat brain
29. Relationships between hyponeophagia, diazepam sensitivity and benzodiazepine receptor binding in eighteen rat genotypes
30. Effect of repeated electroconvulsive treatment on regional concentrations of tachykinins, neurotensin, vasoactive intestinal polypeptide, neuropeptide Y, and galanin in rat brain
31. Differences in morphine reinforcement property in two inbred rat strains: Associations with cortical receptors, behavioral activity, analgesia and the cataleptic effects of morphine
32. Changes of the levels of substance P, diazepam binding inhibitor fragment and neuropeptide Y in brain of high- and low-anxiety inbred rats during stress
33. Effects of central administration of tachi-kinin receptor agonists and antagonists on plus-maze behavior in mice
34. Sub-chronic exposure to opiates in the rat: Effects on brain levels of substance P and calcitonin gene-related peptide during dependence and withdrawal
35. A simple and reliable conflict procedure for testing anti-anxiety agents
36. Substance P release in the rat periaqueductal gray and preoptic anterior hypothalamus after noxious cold stimulation: Effect of selective mu and kappa opioid agonists